{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lysine-Proline-Valine)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 KPV\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> \u306f\u3001Lys-Pro-Val\u30c8\u30ea\u30da\u30d7\u30c1\u30c9 \u2014 \u03b1-\u30e1\u30e9\u30ce\u30b5\u30a4\u30c8\u523a\u6fc0\u30db\u30eb\u30e2\u30f3\uff08\u03b1-MSH\uff09\u306eC\u672b\u7aef\u6297\u708e\u75c7\u30d5\u30e9\u30b0\u30e1\u30f3\u30c8\u3067\u3059\u3002\u5e83\u7bc4\u306a\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f3\u985e\u4f3c\u4f53\u3068\u306f\u7570\u306a\u308a\u3001KPV\u306f <strong>\u8272\u7d20\u6c88\u7740\u6d3b\u6027\u304c\u306a\u304f<\/strong>; its signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation studies. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>KPV\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>KPV<\/strong> \u306f\u30013\u6587\u5b57\u304a\u3088\u30731\u6587\u5b57\u30b3\u30fc\u30c9\u306e\u7565\u79f0\u3067\u3042\u308a\u3001 <strong>Lys-Pro-Val\u30c8\u30ea\u30da\u30d7\u30c1\u30c9<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>\u6297\u708e\u75c7\u4f5c\u7528<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects. Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory studies tripeptides. It is supplied as a high-purity lyophilized powder. For mechanism, IBD studies history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/ja\/kpv-peptide-anti-inflammatory-guide\/\">KPV guide<\/a>. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 3\u3064\u306e\u6297\u708e\u75c7\u7d4c\u8def<\/h2>\n<p>KPV\u306e\u6297\u708e\u75c7\u4f5c\u7528\u306f\u3001\u5c11\u306a\u304f\u3068\u30823\u3064\u306e\u76f8\u88dc\u7684\u306a\u7d4c\u8def\u3092\u901a\u3058\u3066\u4f5c\u7528\u3057\u3001\u3053\u308c\u3089\u3059\u3079\u3066\u304c\u4ed6\u306e\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f3\u6a5f\u80fd\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3053\u3068\u306a\u304f\u3001\u708e\u75c7\u30b7\u30b0\u30ca\u30eb\u3092\u4f4e\u6e1b\u3059\u308b\u3053\u3068\u306b\u53ce\u675f\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>NFkB\u963b\u5bb3<\/strong> \u2014 KPV\u306fNFkB\u306e\u6838\u79fb\u884c\u3092\u963b\u5bb3\u3057\u3001TNF-\u03b1\u3001IL-6\u3001IL-1\u03b2\u3001IL-8\u306a\u3069\u306e\u708e\u75c7\u6027\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u306e\u8ee2\u5199\u3092\u9632\u304e\u307e\u3059\u3002NFkB\u306f\u708e\u75c7\u6027\u907a\u4f1d\u5b50\u767a\u73fe\u306e\u4e3b\u8981\u5236\u5fa1\u56e0\u5b50\u3067\u3042\u308b\u305f\u3081\u3001\u305d\u306e\u6d3b\u6027\u5316\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3067\u3001\u5e83\u7bc4\u306a\u4e0a\u6d41\u306e\u6297\u708e\u75c7\u52b9\u679c\u304c\u5f97\u3089\u308c\u307e\u3059\u3002<\/li>\n<li><strong>\u30de\u30b9\u30c8\u7d30\u80de\u5b89\u5b9a\u5316<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in study models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation studies and topical skin-inflammation models.<\/li>\n<li><strong>\u30da\u30d7\u30c1\u30c9 vs MSH\u5206\u96e2<\/strong> \u2014 KPV\u306fC\u672b\u7aef\u30d5\u30e9\u30b0\u30e1\u30f3\u30c8\u306b\u904e\u304e\u306a\u3044\u305f\u3081\u3001 <strong>MC1R\u3092\u6d3b\u6027\u5316\u3057\u307e\u305b\u3093<\/strong> \uff08\u8272\u7d20\u6c88\u7740\u53d7\u5bb9\u4f53\uff09\u307e\u305f\u306f MC4R\uff08\u899a\u9192\uff0f\u6442\u98df\u53d7\u5bb9\u4f53\uff09\u3067\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u6297\u708e\u75c7\u6d3b\u6027\u3092 \u03b1-MSH \u306e\u4ed6\u306e\u52b9\u679c\u304b\u3089\u30e1\u30ab\u30cb\u30ba\u30e0\u7684\u306b\u5206\u96e2\u3057\u307e\u3059 \u2014 \u3088\u308a\u5e83\u7bc4\u306a MC \u985e\u4f3c\u4f53\uff08\u4f8b\u3048\u3070\u3001 <a href=\"https:\/\/medsbase.com\/ja\/melanotan-ii\/\">Melanotan II<\/a> \u307e\u305f\u306f <a href=\"https:\/\/medsbase.com\/ja\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical studies implication: KPV is a &#8220;clean&#8221; anti-inflammatory tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of studies using full-length MC agonists. <\/p>\n<h2>Published Evidence<\/h2>\n<p>KPV is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis studies<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation studies (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u708e\u75c7<\/strong> \u2014 mast-cell stabilization and histamine-release studies in allergy and atopy models<\/li>\n<li><strong>\u76ae\u819a\u708e\u75c7<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis study models; topical formulations appear in some protocols<\/li>\n<li><strong>\u5275\u50b7\u6cbb\u7652<\/strong> \u2014 anti-inflammatory phase of wound-healing studies, often paired with <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> \u6297\u708e\u75c7\u4f5c\u7528\u3068\u6210\u9577\u56e0\u5b50\u306e\u8907\u5408\u7684\u306a\u30ab\u30d0\u30ec\u30c3\u30b8\u306e\u305f\u3081\u306b<\/li>\n<li><strong>\u95a2\u7bc0\u708e\u75c7<\/strong> \u2014 arthritis and joint-inflammation rodent study models<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 \u4e00\u822c\u7684\u306b\u4f75\u7528\u3055\u308c\u308b <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue studies where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative studies<\/strong> \u2014 \uff5e\u3068\u4e26\u3079\u3066\u6bd4\u8f03 <a href=\"https:\/\/medsbase.com\/ja\/melanotan-ii\/\">Melanotan II<\/a> KYC\uff08Know Your Customer\uff09 <a href=\"https:\/\/medsbase.com\/ja\/pt-141\/\">PT-141<\/a> \u7d14\u7c8b\u306a\u6297\u708e\u75c7\u4f5c\u7528\u3068MC\u53d7\u5bb9\u4f53\u4f5c\u7528\u3092\u5206\u96e2\u3059\u308b\u305f\u3081\u306b<\/li>\n<\/ul>\n<p>\u6297\u708e\u75c7\u30da\u30d7\u30c1\u30c9\u304a\u3088\u3073\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u306b\u95a2\u3059\u308b\u3088\u308a\u5e83\u3044\u80cc\u666f\u306b\u3064\u3044\u3066\u306f\u3001 <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a>. <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase\u3067\u306f\u3001\u4ee5\u4e0b\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u30b5\u30a4\u30ba\u3067KPV\u3092\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies, or topical\/oral routes for GI and skin contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>KPV\u3068\u4ed6\u306e\u6297\u708e\u75c7\uff0f\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f3\u30da\u30d7\u30c1\u30c9\u3068\u306e\u6bd4\u8f03<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30a2\u30df\u30ce\u9178\u6570<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3\u30a2\u30df\u30ce\u9178<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15\u30a2\u30df\u30ce\u9178<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7\u30a2\u30df\u30ce\u9178\uff08\u74b0\u72b6\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e3b\u306a\u6d3b\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6297\u708e\u75c7\u4f5c\u7528\u306e\u307f<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6297\u708e\u75c7\u4f5c\u7528 + \u7d44\u7e54\u4fee\u5fa9 + GH\u53d7\u5bb9\u4f53<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5e83\u7bc4\u306aMC\u4f5c\u52d5\u85ac\uff08MC1-5\uff09<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>MC\u53d7\u5bb9\u4f53\u6d3b\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306a\u3057\uff08C\u672b\u7aef\u306e\u307f\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306a\u3057<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1\u3001MC3\u3001MC4\u3001MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u8272\u7d20\u6c88\u7740\u3078\u306e\u4f5c\u7528<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306a\u3057<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306a\u3057<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5f37\u529b\uff08\u4e3b\u8981\u30b7\u30b0\u30ca\u30eb\uff09<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Study applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">IBD\u3001\u30a2\u30ec\u30eb\u30ae\u30fc\u3001\u76ae\u819a\u708e\u75c7<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u8171\u3001\u6d88\u5316\u7ba1\u3001\u7b4b\u8089\u306e\u56de\u5fa9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30e1\u30e9\u30cb\u30f3\u751f\u6210\u3001\u5149\u4fdd\u8b77\u4f5c\u7528<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation studies, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3001\u6700\u957736\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u7c89\u672b\u306e\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u4e0a\u8a18\u306e\u8868\u306b\u5f93\u3044\u3001\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u9759\u83cc\u6c34\u3092\u6ce8\u5165\u3057\u307e\u3059\u3002\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3066\u304f\u3060\u3055\u3044 \u2014 \u884c\u3046 <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3089\u305a\u306b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u9759\u7f6e\u3057\u307e\u3059\u3002\u6eb6\u6db2\u306f\u6f84\u660e\u3067\u7121\u8272\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> 2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u5f8c\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is KPV used for in studies?<\/h3>\n<p>KPV is used in studies investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>\u3057\u307e\u305b\u3093<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>KPV\u306fMelanotan II\u3084PT-141\u3068\u3069\u3046\u9055\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>KPV\u306f\u03b1-MSH\u306eC\u672b\u7aef\u306b\u3042\u308b3\u30a2\u30df\u30ce\u9178\u306e\u65ad\u7247\u306b\u3059\u304e\u307e\u305b\u3093\u304c\u3001Melanotan II\u3068PT-141\u306f\u5168\u9577\u307e\u305f\u306f\u307b\u307c\u5168\u9577\u306e\u74b0\u72b6MSH\u30a2\u30ca\u30ed\u30b0\u3067\u3059\u3002\u3064\u307e\u308a\u3001KPV\u306f <strong>\u30e1\u30e9\u30ce\u30b3\u30eb\u30c1\u30f3\u53d7\u5bb9\u4f53\u6d3b\u6027\u304c\u306a\u304f<\/strong> \u305d\u306e\u305f\u3081\u3001\u8272\u7d20\u6c88\u7740\uff08MC1R\uff09\u3001\u6027\u7684\u8208\u596e\uff08MC4R\uff09\u3001\u98df\u6b32\uff08MC4R\uff09\u3078\u306e\u5f71\u97ff\u306f\u306a\u304f\u3001NFkB\u7d4c\u8def\u304a\u3088\u3073\u80a5\u6e80\u7d30\u80de\u7d4c\u8def\u3092\u4ecb\u3057\u305f\u6297\u708e\u75c7\u4f5c\u7528\u306e\u307f\u304c\u3042\u308a\u307e\u3059\u3002 <\/p>\n<h3>What is the typical KPV dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies. Some IBD and skin-inflammation uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg. <\/p>\n<h3>KPV\u306fFDA\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related has informed melanocortin drug development broadly, but KPV itself remains. All KPV sold by peptide-studies suppliers is for clinical investigation only. <\/p>\n<h3>Can KPV be taken orally for IBD studies?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis studies. This makes it unusually flexible for GI-inflammation studies where oral delivery targets the GI tract directly. Study protocols vary by model \u2014 SC remains the dominant systemic route. <\/p>\n<h3>KPV\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u308c\u3070\u3088\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a2\u301c8\u00b0C\u306e\u51b7\u8535\u5eab\u3067\u5143\u306e\u5305\u88c5\u306e\u307e\u307e\u3001\u6700\u957736\u30f6\u6708\u5b89\u5b9a\u3002\u6eb6\u89e3\u5f8c\u6eb6\u6db2\uff1a2\u301c8\u00b0C\u306e\u51b7\u8535\u5eab\u3067\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u6eb6\u89e3\u5f8c\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>KPV\u306e\u6eb6\u89e3\u65b9\u6cd5\u3092\u6559\u3048\u3066\u304f\u3060\u3055\u3044\u3002<\/h3>\n<p>\u4e0a\u8a18\u306e\u6eb6\u89e3\u65e9\u898b\u8868\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u30d0\u30a4\u30a2\u30eb\u306e\u5185\u58c1\u306b\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u6cbf\u308f\u305b\u3066\u6ce8\u5165\u3057\u3001\u9759\u304b\u306b\u5186\u3092\u63cf\u304f\u3088\u3046\u306b\u56de\u3057\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u7f6e\u304d\u307e\u3059\u3002\u7d76\u5bfe\u306b <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3089\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>Can KPV and BPC-157 be stacked in studies?<\/h3>\n<p>Yes \u2014 this is one of the most common studies combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> VEGF\u7d4c\u8def\u3092\u4ecb\u3057\u305f\u7d44\u7e54\u4fee\u5fa9\u304a\u3088\u3073\u6210\u9577\u56e0\u5b50\u6d3b\u6027\u3092\u793a\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f5c\u7528\u6a5f\u5e8f\u306f\u91cd\u8907\u3059\u308b\u3068\u3044\u3046\u3088\u308a\u3082\u3001\u76f8\u4e92\u306b\u88dc\u5b8c\u3057\u5408\u3046\u3082\u306e\u3067\u3059\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u5bb9\u91cf\u306e\u30ec\u30bf\u30eb\u30c8\u30eb\u30c1\u30c9\u3092\u53d6\u308a\u63c3\u3048\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u3067\u306f\u3001KPV\u30925 mg\u304a\u3088\u307310 mg\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u3067\u53d6\u308a\u6271\u3063\u3066\u304a\u308a\u307e\u3059\u3002\u5404\u5bb9\u91cf\u306f\u300110\u30d0\u30a4\u30a2\u30eb\u300120\u30d0\u30a4\u30a2\u30eb\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u3067\u3054\u7528\u610f\u3057\u3066\u304a\u308a\u307e\u3059\u3002\u3059\u3079\u3066\u306e\u30d0\u30a4\u30a2\u30eb\u306f99%\u4ee5\u4e0a\u306eHPLC\u7d14\u5ea6\u3067\u4f9b\u7d66\u3055\u308c\u3001\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5206\u6790\u8a3c\u660e\u66f8\u3092\u767a\u884c\u3044\u305f\u3057\u307e\u3059\u3002 <\/p>\n<h3>Does KPV cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical doses. Long-term human safety data are not available. <\/p>\n<h3>KPV\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa. <\/p>\n<h3>How does KPV reduce inflammation in study models?<\/h3>\n<p>KPV\u306f\u03b1-MSH\uff08\u30a2\u30eb\u30d5\u30a1\u30e1\u30e9\u30ce\u30b5\u30a4\u30c8\u523a\u6fc0\u30db\u30eb\u30e2\u30f3\uff09\u306eC\u672b\u7aef\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308a\u3001MC1R\u306e\u6d3b\u6027\u5316\u3092\u4ecb\u3057\u3066\u3001\u89aa\u30da\u30d7\u30c1\u30c9\u306e\u6297\u708e\u75c7\u6d3b\u6027\u306e\u591a\u304f\u3092\u4fdd\u6301\u3057\u3066\u3044\u307e\u3059\u3002\u5927\u8178\u708e\u3084\u8178\u640d\u50b7\u30e2\u30c7\u30eb\u306b\u304a\u3044\u3066\u3001KPV\u306fNF-\u03baB\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3092\u6291\u5236\u3057\u3001\u708e\u75c7\u6027\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\uff08IL-1\u03b2\u3001IL-6\u3001TNF-\u03b1\uff09\u306e\u7523\u751f\u3092\u6e1b\u5c11\u3055\u305b\u3001\u8178\u4e0a\u76ae\u30d0\u30ea\u30a2\u306e\u5b8c\u5168\u6027\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002\u305d\u306e\u5c0f\u3055\u306a\u30b5\u30a4\u30ba\u306b\u3088\u308a\u3001\u30ad\u30e3\u30ea\u30a2\u30bf\u30f3\u30d1\u30af\u8cea\u306b\u4f9d\u5b58\u3057\u306a\u3044\u76f4\u63a5\u7684\u306a\u4e0a\u76ae\u7d30\u80de\u3078\u306e\u53d6\u308a\u8fbc\u307f\u304c\u5bb9\u6613\u306b\u306a\u308a\u307e\u3059\u3002 <\/p>\n<h3>KPV\u3092\u56fd\u969b\u914d\u9001\u3067\u6ce8\u6587\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002MedsBase\u3067\u306f\u3001\u5c02\u7528\u306e\u30da\u30d7\u30c1\u30c9\u914d\u9001\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u901a\u3058\u3001KPV\u3092\u5168\u4e16\u754c\u914d\u9001\u3057\u3066\u304a\u308a\u307e\u3059\u3002\u30da\u30d7\u30c1\u30c9\u306e\u307f\u306e\u3054\u6ce8\u6587\u306b\u306f\u3001\u5f53\u793e\u306e\u30da\u30d7\u30c1\u30c9\u5c02\u7528\u767a\u9001\u30b5\u30fc\u30d3\u30b9\u304c\u9069\u7528\u3055\u308c\u307e\u3059\u3002\u3054\u6ce8\u6587\u54c1\u306f\u6e29\u5ea6\u7ba1\u7406\u68b1\u5305\u3067\u3001\u5b8c\u5168\u306a\u8ffd\u8de1\u60c5\u5831\u4ed8\u304d\u306b\u3066\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002 <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/ja\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/ja\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/ja\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 \u9078\u629e\u7684\u30b0\u30ec\u30ea\u30f3\u4f5c\u52d5\u85ac \u2014 \u30b3\u30eb\u30c1\u30be\u30fc\u30eb\uff0f\u30d7\u30ed\u30e9\u30af\u30c1\u30f3\u3092\u4f34\u308f\u306a\u3044\u30af\u30ea\u30fc\u30f3\u306aGH\u30d1\u30eb\u30b9<\/li>\n<li><a href=\"\/ja\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 \u534a\u6e1b\u671f\u5ef6\u9577\u578bGHRH\u30a2\u30ca\u30ed\u30b0<\/li>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory studies<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD studies history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u7d44\u7e54\u4fee\u5fa9\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u9178\u5316\u30b9\u30c8\u30ec\u30b9\u3092\u8efd\u6e1b<br \/>\n\u2705 \u514d\u75ab\u5fdc\u7b54\u3092\u8abf\u7bc0<br \/>\n\u2705 \u7d30\u80de\u306e\u56de\u5fa9\u529b\u3092\u4fc3\u9032<br \/>\n\u2705 \u4e0a\u76ae\u306e\u5b8c\u5168\u6027\u3092\u9ad8\u3081\u308b<\/p>\n<p><strong>KPV<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":["post-69013","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kpv","product_tag-lysine-proline-valine","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}